A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale

Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials